H1B Salary Data

Home › Employers › Topcon Healthcare Inc.

Topcon Healthcare Inc.: H-1B salaries and sponsorship

Topcon Healthcare Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $147,500.

Applications (LCAs)3
Certified3
Employer addressOakland, NJ
H-1B dependent employerNo
Median offered salary$147,500
Middle half of salaries$131,750–$148,750
10th–90th percentile$122,300–$149,500

Does Topcon Healthcare Inc. sponsor H-1B visas?

Topcon Healthcare Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 17, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Research Scientist, Image Processing R&D1$116,000
Clinical Vision Scientist1$150,000
Scientific Algorithm Image Engineer1$147,500

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20252$133,000
FY20261$147,500

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Scientific Algorithm Image Engineer$147,500
Level III
Milpitas, CAApr 17, 2026Oct 1, 2026Certified
Research Scientist, Image Processing R&D$116,000
Level II
Milpitas, CAJun 2, 2025Oct 1, 2025Certified
Clinical Vision Scientist$150,000
Level IV
La Jolla, CAMay 7, 2025Oct 1, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).